ALEMBIC PHARMA LTD (APLLTD) financials

ALEMBIC PHARMA LTD (APLLTD) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities.

Market Cap: ₹15,510Cr.
Current Price: ₹789
Stock P/E: 19.7
ROE: 12.9%
ROCE: 12.3%
Book Value: ₹286
Dividend Yield: 1.52%
52W High / Low: ₹998/635

In Jun 2026, ALEMBIC PHARMA LTD (APLLTD) reported sales ₹1,868 Cr and net profit ₹197 Cr.

Annual TTM: sales ₹7,025 Cr, net profit ₹734 Cr.

Shareholding: Promoters 69.87% (Jun 2026), FIIs 4.17% (Jun 2026), DIIs 15.93% (Jun 2026), Public 10.00% (Jun 2026), No. of Shareholders 86,796% (Jun 2026).

APLLTD quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1,580	1,406	1,571	1,494	1,796	1,642	1,719	1,868
Expenses	1,321	1,226	1,400	1,280	1,493	1,371	1,445	1,522
Operating Profit	259	180	171	214	303	272	274	346
OPM %	16%	13%	11%	14%	17%	17%	16%	19%
Other Income	29	15	13	8	11	-32	1	14
Interest	18	22	24	23	23	22	19	21
Depreciation	70	70	69	73	76	80	82	83
Profit before tax	200	104	92	126	216	139	173	256
Tax %	17%	17%	18%	18%	17%	18%	-40%	23%
Net Profit	166	86	75	104	179	114	243	197
EPS in Rs	8.43	4.37	3.83	5.27	9.12	5.82	12.37	10.02
Raw PDF	—	—	—	—	—	—	—	—

APLLTD profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	4,133	5,067	5,035	5,149	5,874	6,033	6,651	7,025
Expenses	2,930	3,618	4,127	4,484	4,875	5,131	5,586	5,830
Operating Profit	1,203	1,449	909	665	999	901	1,065	1,195
OPM %	29%	29%	18%	13%	17%	15%	16%	17%
Other Income	125	84	51	3	31	61	-13	-5
Interest	25	13	17	49	54	76	87	85
Depreciation	136	183	285	273	271	277	311	320
Profit before tax	1,167	1,338	658	346	704	609	654	784
Tax %	17%	18%	17%	-0%	5%	17%	2%	—
Net Profit	969	1,097	544	347	666	503	640	734
EPS in Rs	51.42	55.79	27.65	17.64	33.91	25.60	32.58	37.33
Dividend Payout %	19%	25%	36%	45%	32%	43%	37%	—

APLLTD balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	38	38	39	39	39	39	39	39
Reserves	2,675	3,308	5,062	5,251	4,375	4,870	5,155	5,576
Borrowings	1,059	1,687	584	706	710	492	1,194	1,198
Other Liabilities	777	846	958	1,078	1,006	998	1,168	1,338
Total Liabilities	4,549	5,879	6,643	7,074	6,130	6,399	7,556	8,151
Fixed Assets	1,085	1,276	1,774	1,771	2,377	2,536	2,513	2,828
CWIP	1,107	1,570	2,183	2,304	601	524	837	683
Investments	506	833	343	219	229	227	260	271
Other Assets	1,850	2,199	2,344	2,779	2,922	3,112	3,946	4,368
Total Assets	4,549	5,879	6,643	7,074	6,130	6,399	7,556	8,151

APLLTD cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	809	540	1,485	545	730	773	227	809
Cash from Investing Activity	-754	-822	-926	-369	-461	-329	-636	-483
Cash from Financing Activity	80	166	-534	-217	-261	-445	404	-318
Net Cash Flow	135	-116	25	-40	8	-2	-6	8
Free Cash Flow	244	-88	884	124	287	448	-327	376
CFO/OP	110%	61%	119%	74%	118%	78%	30%	83%

APLLTD shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	69.61%	69.61%	69.67%	69.68%	69.74%	69.74%	69.74%	69.87%
FIIs	3.94%	4.17%	3.94%	3.96%	4.04%	4.23%	4.26%	4.17%
DIIs	16.05%	16.05%	16.43%	16.46%	16.30%	16.17%	16.17%	15.93%
Public	10.38%	10.17%	9.96%	9.91%	9.92%	9.84%	9.83%	10.00%
No. of Shareholders	91,429	93,944	91,336	89,013	89,969	87,000	86,432	86,796

APLLTD key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	54	69	30	72	85	83	90	88
Inventory Days	325	375	376	339	280	274	403	370
Days Payable	173	137	148	139	131	126	148	119
Cash Conversion Cycle	207	307	258	272	234	232	345	339
Working Capital Days	44	58	80	83	85	102	94	89
ROCE %	24%	27%	25%	12%	7%	14%	11%	12%

APLLTDUpdated 13 Oct 2026, 5:05

Alembic Pharma Ltd

APLLTDUpdated 13 Oct 2026, 5:05

Market Cap

₹15,510Cr.

Current Price

₹789

High / Low

₹998/635

Stock P/E

19.7

ROE12.9%

ROCE12.3%

Book Value₹286

Face Value₹2.00

Dividend Yield1.52%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1332	14	1167	12	66	98	0	98	4.96
Sep 2023	1479	15	1271	9	67	134	0	134	6.81
Dec 2023	1588	15	1251	3	69	257	9	233	11.87
Mar 2024	1475	10	1186	7	69	216	7	202	10.27
Jun 2024	1476	13	1184	3	69	213	17	176	8.96
Sep 2024	1580	18	1321	29	70	200	17	166	8.43
Dec 2024	1406	22	1226	15	70	104	17	86	4.37
Mar 2025	1571	24	1400	13	69	92	18	75	3.83
Jun 2025	1494	23	1280	8	73	126	18	104	5.27
Sep 2025	1796	23	1493	11	76	216	17	179	9.12
Dec 2025	1642	22	1371	-32	80	139	18	114	5.82
Mar 2026	1719	19	1445	1	82	173	-40	243	12.37
Jun 2026	1868	21	1522	14	83	256	23	197	10.02

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	2019	3	1611	3	44	363	21	287	15.2
Mar 2016	3009	4	2026	7	72	914	24	699	37.06
Mar 2017	2986	3	2353	3	83	550	22	431	22.84
Mar 2018	2945	2	2313	7	102	535	21	422	22.38
Mar 2019	3660	15	2782	6	106	765	20	611	32.42
Mar 2020	4133	25	2930	125	136	1167	17	969	51.42
Mar 2021	5067	13	3618	84	183	1338	18	1097	55.79
Mar 2022	5035	17	4127	51	285	658	17	544	27.65
Mar 2023	5149	49	4484	3	273	346	0	347	17.64
Mar 2024	5874	54	4875	31	271	704	5	666	33.91
Mar 2025	6033	76	5131	61	277	609	17	503	25.6
Mar 2026	6651	87	5586	-13	311	654	2	640	32.58
TTM	7025	85	5830	-5	320	784	—	734	37.33

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	69.87%
FIIs	4.17%
DIIs	15.93%
Public	10%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	69.61%	4.51%	14.22%	11.67%
Dec 2023	69.61%	4.52%	14.51%	11.36%
Mar 2024	69.61%	4.46%	15.39%	10.54%
Jun 2024	69.61%	4.32%	15.47%	10.61%
Sep 2024	69.61%	3.94%	16.05%	10.38%
Dec 2024	69.61%	4.17%	16.05%	10.17%
Mar 2025	69.67%	3.94%	16.43%	9.96%
Jun 2025	69.68%	3.96%	16.46%	9.91%
Sep 2025	69.74%	4.04%	16.3%	9.92%
Dec 2025	69.74%	4.23%	16.17%	9.84%
Mar 2026	69.74%	4.26%	16.17%	9.83%
Jun 2026	69.87%	4.17%	15.93%	10%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	38	796	194	484	1511	489	83	33	906	1511
Mar 2016	38	1493	0	651	2182	697	92	37	1355	2182
Mar 2017	38	1830	8	634	2509	799	348	103	1259	2509
Mar 2018	38	2157	622	862	3678	918	741	299	1720	3678
Mar 2019	38	2675	1059	777	4549	1085	1107	506	1850	4549
Mar 2020	38	3308	1687	846	5879	1276	1570	833	2199	5879
Mar 2021	39	5062	584	958	6643	1774	2183	343	2344	6643
Mar 2022	39	5251	706	1078	7074	1771	2304	219	2779	7074
Mar 2023	39	4375	710	1006	6130	2377	601	229	2922	6130
Mar 2024	39	4870	492	998	6399	2536	524	227	3112	6399
Mar 2025	39	5155	1194	1168	7556	2513	837	260	3946	7556
Mar 2026	39	5576	1198	1338	8151	2828	683	271	4368	8151

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	180	-199	18	-1
Mar 2016	848	-292	-276	280
Mar 2017	327	-511	-96	-280
Mar 2018	305	-794	498	9
Mar 2019	809	-754	80	135
Mar 2020	540	-822	166	-116
Mar 2021	1485	-926	-534	25
Mar 2022	545	-369	-217	-40
Mar 2023	730	-461	-261	8
Mar 2024	773	-329	-445	-2
Mar 2025	227	-636	404	-6
Mar 2026	809	-483	-318	8

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	61	45	57	77	54	69	30	72	85	83	90	88
Inventory Days	195	240	237	274	325	375	376	339	280	274	403	370
Days Payable	162	225	177	246	173	137	148	139	131	126	148	119
Cash Conversion Cycle	95	60	117	105	207	307	258	272	234	232	345	339
Working Capital Days	42	57	82	94	44	58	80	83	85	102	94	89
ROCE %	41%	72%	32%	23%	24%	27%	25%	12%	7%	14%	11%	12%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ALEMBIC PHARMA LTD (APLLTD)?

The reported market capitalisation for ALEMBIC PHARMA LTD (APLLTD) is ₹15,510Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of APLLTD?

The current price shown for ALEMBIC PHARMA LTD (APLLTD) on Fincrux is ₹789 with a 52-week high/low of ₹998/635.

What is the P/E ratio of ALEMBIC PHARMA LTD (APLLTD)?

The stock P/E for ALEMBIC PHARMA LTD (APLLTD) is 19.7 on Fincrux, with ROE at 12.9% and ROCE at 12.3%.

What were APLLTD latest quarterly results?

For Jun 2026, ALEMBIC PHARMA LTD (APLLTD) reported sales ₹1,868 Cr and net profit ₹197 Cr (figures in ₹ crore unless noted).

What are APLLTD annual sales and net profit?

For TTM, ALEMBIC PHARMA LTD (APLLTD) shows sales of ₹7,025 Cr and net profit of ₹734 Cr on the Fincrux profit & loss statement.

Who owns ALEMBIC PHARMA LTD (APLLTD)?

Latest shareholding for ALEMBIC PHARMA LTD (APLLTD) on Fincrux: Promoters 69.87% (Jun 2026), FIIs 4.17% (Jun 2026), DIIs 15.93% (Jun 2026), Public 10.00% (Jun 2026), No. of Shareholders 86,796% (Jun 2026).

Where can I find ALEMBIC PHARMA LTD (APLLTD) financials?

ALEMBIC PHARMA LTD (APLLTD) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show APLLTD balance sheet and cash flow?

Yes. The ALEMBIC PHARMA LTD (APLLTD) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 5:05